"10.1371_journal.pone.0052543","plos one","2013-01-09T00:00:00Z","David S Terman; Benjamin L Viglianti; Rahima Zennadi; Diane Fels; Richard J Boruta; Hong Yuan; Mathew R Dreher; Gerald Grant; Zahid N Rabbani; Ejung Moon; Lan Lan; Joseph Eble; Yiting Cao; Brian Sorg; Kathleen Ashcraft; Greg Palmer; Marilyn J Telen; Mark W Dewhirst","Molecular Genetics Program, Jenomic, Carmel, California, United States of America; Department of Radiology, University of Michigan, Ann Arbor, Michigan, United States of America; Department of Medicine, Division of Hematology, Duke University Medical Center, Durham, North Carolina, United States of America; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, United States of America; Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina, United States of America; Department of Radiology, University of North Carolina, Chapel Hill, North Carolina, United States of America; National Institutes of Health, Clinical Center, Diagnostic Radiology Department, Bethesda, Maryland, United States of America; Department of Surgery, Division of Neurosurgery, Duke University Medical Center, Durham, North Carolina, United States of America; Department of Biostatistics, Duke University Medical Center, Durham, North Carolina, United States of America; Department of Radiology, Mayo Clinic Foundation, Rochester, Minnesota, United States of America; Department of Surgery, Division of Neurooncology, Duke University Medical Center, Durham, North Carolina, United States of America; Cancer Diagnosis Program, National Cancer Institute, Bethesda, Maryland, United States of America","Conceived and designed the experiments: DST. Performed the experiments: DST BLV RZ HY MRD GG ZNR EM JE YC BS KA RJB DF. Analyzed the data: DST MWD MJT LL GP BLV RZ BS. Wrote the paper: DST MWD.","The authors have read the journal's policy and have the following conflicts: DST is sole inventor of US patent 7,803,637 filed August 30, 2000, issued September 28, 2010. All other authors have no competing interests. Dr. David S. Terman is employed by Jenomic. This does not alter his adherence to all the PLOS ONE policies on sharing data and materials. Reovirus Dearing Type 3 was provided by Oncolytics Biotech Inc. (Calgary, Canada). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","01","David S Terman","DST",18,FALSE,1,14,8,2,TRUE,TRUE,FALSE,0,NA,FALSE
